Rakovina Therapeutics Inc.
RKV.V
TSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.24M | -2.10M | -1.52M | -1.06M | -741.40K |
| Total Depreciation and Amortization | 98.10K | 96.60K | 92.10K | 96.50K | 99.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 336.80K | 28.10K | 167.50K | 56.20K | 26.70K |
| Change in Net Operating Assets | 54.30K | -218.50K | 397.40K | -349.60K | -408.30K |
| Cash from Operations | -751.60K | -2.19M | -861.90K | -1.26M | -1.02M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 0.00 | 1.35M | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 3.63M | -- | 2.93M | 300.00K |
| Repurchase of Common Stock | -16.70K | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -8.70K | -147.30K | -- | -107.60K | -34.80K |
| Cash from Financing | -18.40K | 3.49M | -- | 2.01M | 194.40K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -770.00K | 1.31M | -861.90K | 755.60K | -829.50K |